This approach has identified tumor IFN-γ signaling as essential for sensitivity to anti-tumor T cells, but has focused on melanoma10,27,28 or a limited number of mouse syngeneic cell lines,29,30,31,32 leaving other indications for ICB, such as CRC,33 relatively unexplored. This evidence concerns the gene IFNG and colorectal carcinoma.